# FDA Inspection 831868 - Central California Blood Center - May 14, 2013

Source: https://www.keypedia.com/records/fda_inspections/central-california-blood-center/0914674c-45b1-4928-b8a1-dae6cbf965ab
Source feed: FDA_Inspections

> FDA Inspection 831868 for Central California Blood Center on May 14, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 831868
- Company Name: Central California Blood Center
- Inspection Date: 2013-05-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 928271 - 2015-05-20](https://www.keypedia.com/records/fda_inspections/central-california-blood-center/33230919-bd2b-4b73-bf73-079010e47ac0)
- [FDA Inspection 715756 - 2011-03-08](https://www.keypedia.com/records/fda_inspections/central-california-blood-center/272a01d2-987a-44cc-b7e5-fa0c6162568f)

Company: https://www.keypedia.com/companies/central-california-blood-center/4e498bd9-53c8-4e4d-9b48-21eb396fddd3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d